Header cover image

Japanese (NIKKEI) Life Sciences Industry Analysis

UpdatedDec 10, 2025
DataAggregated Company Financials
Companies14
  • 7D-4.8%
  • 3M8.1%
  • 1Y-0.3%
  • YTD0.2%

Over the last 7 days, the Life Sciences industry has dropped 11%, driven by Immuno-Biological Laboratories declining 43%. Meanwhile, Shin Nippon Biomedical Laboratories actually outperformed within the industry, gaining 9.0% in the last week. The industry has fallen 3.5% in the last year. Earnings are forecast to grow by 6.0% annually.

Industry Valuation and Performance

Has the Japanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 10 Dec 2025JP¥160.3bJP¥67.6bJP¥702.4m18.3x228.2x2.4x
Fri, 07 Nov 2025JP¥133.0bJP¥66.5bJP¥1.5b15.6x91.1x2x
Sun, 05 Oct 2025JP¥143.6bJP¥66.5bJP¥1.5b16.6x98.4x2.2x
Tue, 02 Sep 2025JP¥149.3bJP¥66.5bJP¥1.5b16.7x102.3x2.2x
Thu, 31 Jul 2025JP¥141.4bJP¥66.0bJP¥1.1b16.5x125.3x2.1x
Sat, 28 Jun 2025JP¥140.7bJP¥66.0bJP¥1.1b16.3x124.5x2.1x
Mon, 26 May 2025JP¥131.8bJP¥66.0bJP¥1.1b16.5x116.3x2x
Wed, 23 Apr 2025JP¥131.4bJP¥63.8bJP¥963.0m14.1x136.5x2.1x
Fri, 21 Mar 2025JP¥162.4bJP¥64.8bJP¥927.4m15.5x175.1x2.5x
Sun, 16 Feb 2025JP¥168.8bJP¥65.3bJP¥1.0b14.8x168.5x2.6x
Tue, 14 Jan 2025JP¥164.8bJP¥62.0bJP¥440.7m17.8x373.9x2.7x
Thu, 12 Dec 2024JP¥162.3bJP¥62.0bJP¥825.9m17x196.6x2.6x
Sat, 09 Nov 2024JP¥157.9bJP¥62.3bJP¥1.5b20.9x108.4x2.5x
Mon, 07 Oct 2024JP¥155.6bJP¥61.5bJP¥1.8b18.2x84.5x2.5x
Wed, 04 Sep 2024JP¥164.4bJP¥61.5bJP¥2.1b20x77.9x2.7x
Fri, 02 Aug 2024JP¥160.6bJP¥61.8bJP¥3.2b23.9x49.6x2.6x
Sun, 30 Jun 2024JP¥168.9bJP¥61.8bJP¥3.2b26.7x52.2x2.7x
Tue, 28 May 2024JP¥162.6bJP¥61.8bJP¥3.4b24.9x48.5x2.6x
Thu, 25 Apr 2024JP¥180.0bJP¥62.3bJP¥3.3b14.1x54.7x2.9x
Sat, 23 Mar 2024JP¥232.5bJP¥155.4bJP¥8.6b14x27x1.5x
Mon, 19 Feb 2024JP¥229.3bJP¥155.3bJP¥8.7b14.6x26.4x1.5x
Wed, 17 Jan 2024JP¥236.1bJP¥167.1bJP¥8.5b15.7x27.8x1.4x
Fri, 15 Dec 2023JP¥231.7bJP¥167.4bJP¥8.7b14.5x26.7x1.4x
Sun, 12 Nov 2023JP¥236.0bJP¥168.2bJP¥9.1b14.5x25.9x1.4x
Tue, 10 Oct 2023JP¥239.8bJP¥179.3bJP¥12.8b15.1x18.8x1.3x
Thu, 07 Sep 2023JP¥270.0bJP¥179.3bJP¥12.8b16.9x21.1x1.5x
Sat, 05 Aug 2023JP¥274.6bJP¥179.8bJP¥13.7b17.5x20x1.5x
Mon, 03 Jul 2023JP¥282.6bJP¥178.5bJP¥16.2b17.5x17.4x1.6x
Wed, 31 May 2023JP¥282.4bJP¥178.2bJP¥15.9b16.4x17.7x1.6x
Fri, 28 Apr 2023JP¥285.9bJP¥171.9bJP¥13.3b16.5x21.5x1.7x
Sun, 26 Mar 2023JP¥310.4bJP¥171.9bJP¥13.3b16.7x23.4x1.8x
Tue, 21 Feb 2023JP¥310.5bJP¥171.6bJP¥13.2b17.1x23.5x1.8x
Thu, 19 Jan 2023JP¥290.2bJP¥166.1bJP¥16.2b14.8x17.9x1.7x
Sat, 17 Dec 2022JP¥312.4bJP¥165.5bJP¥16.0b15.3x19.5x1.9x
Price to Earnings Ratio

19.5x


Total Market Cap: JP¥312.4bTotal Earnings: JP¥16.0bTotal Revenue: JP¥165.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Life Sciences Industry Price to Earnings3Y Average 82.5x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 224x which is higher than its 3-year average PE of 82.4x.
  • The 3-year average PS ratio of 2.0x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 65% per year over the last three years,
  • Revenues have also declined 26% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market1.28%
Healthcare-0.082%
Life Sciences-4.75%
Clinical Research and Equipment-4.75%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2395 Shin Nippon Biomedical LaboratoriesJP¥1.93k9.0%
+JP¥6.7b
22.4%PE17.3x
6190 PhoenixBioJP¥547.005.4%
+JP¥113.4m
55.4%PS1.5x
6090 Human Metabolome TechnologiesJP¥660.000.3%
+JP¥11.4m
7.5%PE19.3x

Latest News